Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A 2024-01-03 18:10
Sciwind Biosciences Announces Positive Topline Results from Phase 3 Clinical Trial of Ecnoglutide (XW003), a Long-acting cAMP Signaling Biased GLP-1 Analog, in Adult Patients with Type 2 Diabetes in China 2024-01-03 10:00
WuXi XDC Enters into Partnership Agreement with IntoCell, Enabling Clients to Accelerate ADC Discovery and Development 2024-01-03 09:28
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca 2024-01-02 22:00
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology 2024-01-02 22:00
Gannex Announces Positive Interim Results from 52-Week Phase II Clinical Trial of Once-Daily ASC41 Tablet in Patients with Biopsy-Confirmed Non-alcoholic Steatohepatitis 2024-01-02 20:06
Ascentage Pharma to Present at 42nd J.P. Morgan Healthcare Conference 2024-01-02 11:58
Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity 2024-01-02 08:00
TiumBio Secures KRW 38.5 Billion in Anticipation of Upcoming Clinical Data 2023-12-29 21:00
ANAESTHESIOLOGIST HERO, DOCTOR'S QUICK THINKING SAVES CYCLIST'S LIFE DURING LEKAS NIGHT RIDE 2023 2023-12-29 17:20
Positive Results In The Interim Analysis Of The Clinical Trial Of Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines 2023-12-29 12:33
Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT) 2023-12-29 07:30
HANSIZHUANG Sets Sail in Indonesia Market 2023-12-28 21:51
RemeGen's Pioneering RC88 Receives IND Approval from US FDA for Platinum-Resistant Recurrent Ovarian Cancer Treatment 2023-12-28 15:45
Innovent and Xuanzhu Enter into Clinical Trial Collaboration Investigating Combination Therapy of Sintilimab (PD-1 inhibitor) and A Novel ADC Candidate for Advanced Solid Tumors in China 2023-12-28 08:00
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA 2023-12-27 20:50
Seegene obtains ISO45001 certification 2023-12-27 20:00
Rx-360® Announces 2024 Board of Directors 2023-12-27 13:00
Caliway to Present CBL-514 Phase 2 Study Results for Subcutaneous Fat Reduction at IMCAS 2024 2023-12-27 11:49
PharmaBlock Opens HPAPI GMP Facility at Zhejiang Manufacturing Site 2023-12-27 11:37
1 58 59 60 61 62 413